Related references
Note: Only part of the references are listed.Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomas
Marie Dilly-Feldis et al.
PEDIATRIC BLOOD & CANCER (2019)
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Epstein-Barr Virus (EBV) Positive Classical Hodgkin Lymphoma of Iraqi Children: An Immunophenotypic and Molecular Characterization of Hodgkin/Reed-Sternberg Cells
Arianna Di Napoli et al.
PEDIATRIC BLOOD & CANCER (2013)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection
Mario Henrique M. Barros et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
Increased programmed death-1+tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival
Simone Muenst et al.
HUMAN PATHOLOGY (2009)
Share Paper
